|
||
Article |
Correspondence to Jack E. Dixon: jedixon{at}ucsd.edu
Lafora disease (LD) is a progressive myoclonic epilepsy resulting in severe neurodegeneration followed by death. A hallmark of LD is the accumulation of insoluble polyglucosans called Lafora bodies (LBs). LD is caused by mutations in the gene encoding the phosphatase laforin, which reportedly exists solely in vertebrates. We utilized a bioinformatics screen to identify laforin orthologues in five protists. These protists evolved from a progenitor red alga and synthesize an insoluble carbohydrate whose composition closely resembles LBs. Furthermore, we show that the kingdom Plantae, which lacks laforin, possesses a protein with laforin-like properties called starch excess 4 (SEX4). Mutations in the Arabidopsis thaliana SEX4 gene results in a starch excess phenotype reminiscent of LD. We demonstrate that Homo sapiens laforin complements the sex4 phenotype and propose that laforin and SEX4 are functional equivalents. Finally, we show that laforins and SEX4 dephosphorylate a complex carbohydrate and form the only family of phosphatases with this activity. These results provide a molecular explanation for the etiology of LD.
| Introduction |
|---|
|
|
|---|
Recessive mutations in EPM2B (epilepsy of progressive myoclonus type 2 gene B)/NHLRC1 (Chan et al., 2003), which encodes the E3 ubiquitin ligase malin (Chan et al., 2003; Gentry et al., 2005), are responsible for
40% of LD cases (Ianzano et al., 2005). Of the LD cases not attributed to mutations in EPM2B,
48% result from recessive mutations in EPM2A (epilepsy of progressive myoclonus type 2 gene A; Minassian et al., 1998; Serratosa et al., 1999; Ianzano et al., 2005). EPM2A encodes laforin, which contains a carbohydrate-binding module (CBM) family 20 (CBM20; Wang et al., 2002) domain followed by the canonical dual specificity phosphatase (DSP) active site motif HCXXGXXRS/T (Cx5R) (Fig. 1 A; Denu et al., 1996; Yuvaniyama et al., 1996; Minassian et al., 1998).
The CBM of laforin binds complex carbohydrates in vivo and in vitro (Wang et al., 2002), and the DSP motif can hydrolyze phosphotyrosine and phosphoserine/threonine substrates in vitro (Ganesh et al., 2000; Wang et al., 2002). However, no group has detected endogenous laforin localization in tissue culture cells or in wild-type tissues likely as a result of low levels of accumulation (Chan et al., 2004; our unpublished data).
|
Ganesh et al. (2002) disrupted the EPM2A locus in a mouse model. Although this model faithfully recapitulated the disease, it yielded no molecular explanation for LD. Similarly, Chan et al. (2004) generated a transgenic mouse overexpressing inactivated laforin, and this mouse model also developed LD. Despite the availability of these two LD mouse models, the molecular etiology of LD remained unexplained. These limitations demonstrate the need to develop alternative model systems to elucidate the biology of LD. Although a molecular mechanism to explain LD has remained elusive, data cumulatively place laforin in the context of being intimately, if not directly, involved in regulating glycogen metabolism. Therefore, we focused on this indisputable aspect of LD for clues to its molecular etiology.
Insoluble glycogen, starch, and floridean starch
Glycogen is produced in the cytoplasm of the majority of archaebacterial, bacterial, fungal, and animal species. It is a water-soluble polymer composed of
-1,4-glycosidic linkages between glucose residues, with branches occurring in a continuous pattern every 12–14 residues via
-1,6-glycosidic linkages. Almost every study on LD refers to LBs as insoluble glycogen. However, definitive biochemical studies on LBs found that the arrangement and pattern of branching in LBs most closely resemble amylopectin (Yokoi et al., 1967, 1968; Sakai et al., 1970).
Amylopectin, like glycogen, is composed of
-1,4-glycosidic linkages with
-1,6-glycosidic branches but with branches arranged in a discontinuous pattern every 12–20 residues. This discontinuous and decreased amount of branching renders amylopectin insoluble. Amylopectin is one of the two components of starch, which is produced in the plastid of green plants (Viridaeplantae). Starch is an insoluble, semicrystalline heterogeneous mixture of 10–25% amylose and 75–90% amylopectin. Plants synthesize starch in chloroplasts during daylight as a transient carbon store that is used during the dark cycle to generate a usable reduced form of carbon in the absence of photosynthesis.
Floridean starch is another insoluble carbohydrate that has similar biochemical properties to amylopectin (Peat et al., 1959; Coppin et al., 2005). Floridean starch is synthesized in the cytoplasm of a variety of protists (i.e., unicellular eukaryotes) and is used as an energy source during specific stages of their life cycle. Floridean starch, like LBs and amylopectin, is made of glucose polymers with branches every 12–20+ residues in a discontinuous pattern (Coppin et al., 2005). Thus, floridean starch, amylopectin, and LBs have been described as possessing similar characteristics.
| Results |
|---|
|
|
|---|
The sequence of the T. gondii genome, like the genome of many protists, was not accessible via GenBank when we initiated this study. Therefore, we searched the T. gondii database (ToxoDB; Kissinger et al., 2003) for a laforin orthologue. We used the criteria that a laforin orthologue must contain both an amino-terminal CBM and a carboxy-terminal DSP domain (Fig. 1 A). DSP domains are readily recognized by the protein families database (pfam; Bateman et al., 2004) and the National Center for Biotechnology Information's (NCBI) conserved domain database (CDD; Marchler-Bauer et al., 2005). However, CBMs are very degenerate at the primary amino acid level, and neither database consistently recognizes any of the 45 CBM families. Because CDD and pfam do not reliably recognize CBMs, we devised a multitiered search strategy to identify laforin orthologues (Fig. 1 B). First, we performed BLASTp (Altschul et al., 1997) searches using the DSP motif HCXXGXXR as an index sequence and identified 20 T. gondii proteins containing this motif. Because laforin contains an amino-terminal CBM and CBMs contain 80–100 amino acids, we eliminated two of these proteins because their HCXXGXXR motif was within the first 80 amino acids. We next performed a secondary BLAST using the NCBI nonredundant (nr) database with each of the remaining 18 proteins minus their DSP domain. If the protein contained a CBM, the BLAST identified other CBM-containing proteins. Using this strategy, we identified one protein, which we refer to as T. gondii laforin (Tg-laforin), that met the aforementioned criteria. Tg-laforin and Homo sapiens laforin (Hs-laforin) are 37% identical (Fig. 1 C). Importantly, Tg-laforin contains all of the residues important for carbohydrate binding as well as the signature residues of a DSP (Fig. 1 A).
With the discovery of a putative laforin orthologue in T. gondii, we extended our search methods to identify additional orthologues using a variety of genome databases (Table S1, available at http://www.jcb.org/cgi/content/full/jcb.200704094/DC1). Using this strategy, we identified laforin orthologues in the four classes of vertebrates with sequenced genomes (mammals, aves, amphibians, and osteichthyes; Fig. 1, A and D). In addition, we identified putative laforin orthologues in four additional protists: Eimeria tenella, Tetrahymena thermophila, Paramecium tetraurelia, and Cyanidioschyzon merolae (Fig. 1, A and C). Although Hs-laforin contains 331 amino acids, the putative protist orthologues varied in predicted size from 323 to 727 amino acids. However, each putative orthologue contained the signature amino acids of a CBM20 and DSP; that is, four invariant aromatic amino acids (Hs-laforin F5, W32, W60, and W99) as well as DX30CX2GX2R, respectively (Fig. 1 A). Despite exhaustive efforts (we searched
170 eukaryotic genomes and
670 bacterial and archaeal genomes), we did not identify any other putative laforin orthologues. Thus, laforin is absent in all traditional nonvertebrate model organisms (e.g., yeast, fly, and worms). Laforin orthologues exist in all classes of vertebrates in which sequence data is available and in the five protists that we identified (Fig. 1, A, C, and D).
Biochemical properties and subcellular localization of laforin orthologues
C. merolae laforin (Cm-laforin) shares the least identity with Hs-laforin (Fig. 1 C). As such, we reasoned that if it exhibited similar in vitro characteristics as Hs-laforin, the other putative orthologues were likely to as well. To test whether the identified protist proteins had similar biochemical characteristics as Hs-laforin and were thus laforin orthologues, we cloned the putative orthologue from C. merolae (Cm-laforin) and purified recombinant protein from bacteria (Fig. S1 A, available at http://www.jcb.org/cgi/content/full/jcb.200704094/DC1). Characteristic of all DSPs, Hs-laforin exhibits phosphatase activity against the artificial substrate para-nitrophenylphosphate (p-NPP; Fig. 2 A; Ganesh et al., 2000).
Cm-laforin also used p-NPP as an artificial substrate with similar kinetics as Hs-laforin (Table I) and displayed a similar specific activity (Fig. 2 A).
In addition to activity against p-NPP, we recently showed that recombinant Hs-laforin releases phosphate from amylopectin (Worby et al., 2006) and that this activity is unique to laforin (Worby et al., 2006). Additionally, we fused the CBM of laforin to the DSP VH1 related (VHR) and demonstrated that although this fusion protein was an active phosphatase, it did not liberate phosphate from amylopectin (Worby et al., 2006). Fig. 2 B shows that like Hs-laforin, Cm-laforin displays a robust ability to release phosphate from amylopectin, whereas VHR does not hydrolyze phosphate from amylopectin. As predicted, the catalytically inactive Cm-laforin–C/S mutant displayed no activity against either substrate (Fig. 2, A and B). Additionally, Tg-laforin also displayed activity against both p-NPP and amylopectin (unpublished data).
|
|
While laforin from all three species binds
-glucans in vitro, this result may not reflect the biological localization of laforin. Moreover, the localization of Hs-laforin has never been determined in wild-type cells or tissues (Chan et al., 2004; our unpublished data). Because we identified multiple new systems to study laforin, we investigated laforin's localization in C. merolae. A C. merolae cell contains a chloroplast, mitochondrion, and nucleus and, when grown in continuous light, accumulates vast storages of floridean starch (Fig. 2 D, schematic; Viola et al., 2001). We fixed C. merolae cells and probed them with an affinity-purified
–Cm-laforin antibody. We found that endogenous Cm-laforin localized in punctate accumulations throughout the cytoplasm of cells (Fig. 2 D). To further define the localization of Cm-laforin, we performed immunogold electron microscopy staining. Ultra-thin sections of C. merolae cells were probed with the affinity-purified
–Cm-laforin antibody and a 10-nm gold particle–conjugated goat
–rabbit secondary antibody. Positive staining was observed surrounding the floridean starch granules (Fig. 2 E, arrowheads). No Cm-laforin was observed within the granules because before sectioning, no protein would have access to this region. In addition, no background staining was observed with the secondary antibody alone (Fig. S3, available at http://www.jcb.org/cgi/content/full/jcb.200704094/DC1). Thus, as we hypothesized, endogenous laforin binds the outer region of insoluble carbohydrates.
Cm-laforin and Tg-laforin possess the same three in vitro properties as Hs-laforin: both use p-NPP as an artificial substrate, bind amylopectin, and release phosphate from amylopectin. Accordingly, the laforin orthologues in vertebrates and the five mentioned protists contain the critical signature primary amino acid structure of a CBM20 and DSP. Thus, our integrated bioinformatics searches for combined CBM and DSP domains correctly predicted the biochemical properties of Cm-laforin. Because the laforin orthologues are the only proteins in any of these genomes that contain a CBM and DSP, we hypothesized that these organisms may have acquired laforin from a common ancestor.
Evolutionary lineage of laforin
The key to the evolutionary lineage of laforin lies in the origin of the aforementioned five protists. The chromalveolate hypothesis postulates (Cavalier-Smith, 1999) that a distinct sequence of events led to the evolution of the kingdom Plantae and to subsequent progeny, including the five aforementioned protists. As illustrated in Fig. 3 A, a mitochondriate protist engulfed a cyanobacterium (Cavalier-Smith, 1982; Bhattacharya and Medlin, 1998) and eventually gave rise to the kingdom Plantae (Cavalier-Smith, 2004).
Once Plantae was established, a second endosymbiosis involving red algae (Gillott and Gibbs, 1980) gave rise to the chromalveolates (Fig. 3 B; Cavalier-Smith, 1999). These engulfments were accompanied with the coevolution of "various manifestations of mitochondria" (Embley and Martin, 2006) and various forms of carbohydrate storage (Viola et al., 2001). These combined evolutionary events resulted in organisms possessing a mitosome, a hydrogenosome, or a true mitochondrion, and some organisms evolved floridean starch as their storage carbohydrate. We hypothesized that interspersed within these evolutionary events, organisms maintained, gained, or lost laforin.
|
A laforin-like protein in plants
Protists such as T. gondii use insoluble floridean starch as an energy source when transitioning from inactive/hibernating life cycle stages to active/replicative stages (for review see Coppin et al., 2003). Likewise, C. merolae, a red alga that contains laforin, synthesizes insoluble floridean starch during the day and uses it as a source of energy at night. Plants have a similar diurnal cycle, producing insoluble carbohydrate in the form of starch during the day and catabolizing it during the night. Because Hs-laforin has been implicated in carbohydrate metabolism and we show that Cm-laforin binds and releases phosphate from amylopectin, we hypothesized that laforin plays a vital role in insoluble carbohydrate metabolism. Thus, we predicted that plants would also have a laforin-like activity; however, we were unable to identify a laforin orthologue in plants. Recently, several starch excess mutants that accumulate starch have been described in plants (Blennow et al., 2002; Smith et al., 2005; Zeeman et al., 2007); one of these is attributed to mutations in the starch excess 4 (SEX4) gene (At3g52180; Niittyla et al., 2006). Niittyla et al. (2006) and Kerk et al. (2006) demonstrated that the Arabidopsis thaliana SEX4 gene (previously identified as a phosphatase and called AtPTPKIS1; Fordham-Skelton et al., 2002) encodes a protein containing a chloroplast-targeting peptide (cTP) and DSP domain at its amino terminus followed by a CBM-like domain at its carboxy terminus (Fig. 4 A), suggesting that SEX4 might be a laforin-like phosphatase (Niittyla et al., 2006).
|
To ascertain whether SEX4 possesses biochemical properties similar to laforin, we cloned A. thaliana SEX4 and assayed purified recombinant SEX4 protein (At-SEX4; Fig. S1 B). Because the cTP of SEX4 is highly hydrophobic and renders the protein insoluble, we deleted the first 52 amino acids and used purified recombinant HIS-tagged
52-SEX4 for our assays (Fig. S1 B). We found that
52-SEX4 has a similar specific activity and possesses similar kinetics as Hs-laforin against p-NPP (Fig. 4 E and Table I) and efficiently liberates phosphate from amylopectin (Fig. 4 F). Conversely, mutation of the active site cysteine to serine abolished these activities (Fig. 4, E and F). Additionally, wild-type (
52-SEX4) and catalytically inactive SEX4 (
52-SEX4-C198S) bind amylopectin similar to Hs-laforin (Fig. 4 G). Importantly, mutations in key conserved AMPKß-GBD residues that form essential hydrogen bonds with the sugar (Polekhina et al., 2003, 2005) abolish this interaction (Fig. 4 G) while minimally affecting the phosphatase activity of SEX4 (Fig. S4 A, available at http://www.jcb.org/cgi/content/full/jcb.200704094/DC1). These mutations considerably reduced the ability of SEX4 to release phosphate from amylopectin (Fig. S4 B). Thus, like Cm-laforin, SEX4 must also be positioned correctly via the CBM in order for the DSP domain to dephosphorylate amylopectin.
Clearly, SEX4 and the laforins contain both a functional CBM and a DSP domain highly specific for dephosphorylating amylopectin. Additionally, we speculate that they are involved in insoluble carbohydrate metabolism. Because carbohydrate metabolism evolved independently in the kingdom Plantae and kingdom Animalia, the use of similar protein modules to regulate a key feature of carbohydrate metabolism in these lineages is a striking example of convergent evolution and strongly suggests that laforin and SEX4 might be functional equivalents.
SEX4 is a functional equivalent of laforin
The SEX4 locus was recently mapped in A. thaliana to At3g52180, and multiple mutations in this gene display a starch excess phenotype (Niittyla et al., 2006; Sokolov et al., 2006). One characterized mutation is the sex4-3 allele that contains an Agrobacterium transferred DNA (T-DNA) insertion in the sixth exon (Niittyla et al., 2006) and leads to the disruption of SEX4 expression (Fig. 5 A).
Because laforin and SEX4 are the only reported proteins in any kingdom that contain both functional CBM and DSP domains and because mutations in the gene expressing either protein results in aberrant carbohydrate accumulation, we postulated that SEX4 and laforin could be functional equivalents.
|
| Discussion |
|---|
|
|
|---|
We demonstrate that laforin is not merely restricted to the genomes of vertebrates but is well conserved in the protists T. gondii, E. tenella, T. thermophila, P. tetraurelia, and C. merolae. Laforin's evolutionary lineage shows that it originated in a primitive red alga during early eukaryotic evolution. Despite its early origin, laforin was only maintained by organisms that synthesize floridean starch (such as the aforementioned five protists) and organisms that inhibit the production of insoluble carbohydrates (i.e., all vertebrates). Organisms that no longer performed either of these processes lost laforin. Conversely to laforin, we show that although SEX4 contains similar domains as laforin, its lineage differs in that SEX4 is conserved in all land plants as well as in C. reinhardtii, a close descendent of primitive green algae. Despite their different lineages, Hs-laforin performs the same function as the plant protein SEX4; thus, we propose that laforin and SEX4 are functional equivalents.
It must be noted that although laforin and SEX4 share a common function and similar domains, they are not orthologous proteins. They are not orthologues because (1) although they share similar CBMs, the CBMs belong to different classes and differ considerably with respect to the primary amino acids that are important for binding carbohydrates, and (2) the DSP and CBM of laforin and SEX4 are arranged in opposite orientations. Thus, it is likely that red and green algae independently evolved a phosphatase via convergent evolution that utilizes a similar mechanism to regulate insoluble carbohydrate metabolism.
Despite the independent means by which laforin and SEX4 evolved, they both dephosphorylate the same carbohydrate substrate and constitute a unique family of phosphatases. In addition, we demonstrate that endogenous Cm-laforin localizes around the floridean starch granules. Although most studies thus far suggest a carbohydrate substrate for laforin and SEX4, it is possible that they bind their respective amylopectin-like material (insoluble glycogen and starch, respectively) and dephosphorylate a proteinacious substrate. This proteinacious substrate would likely be involved in regulating carbohydrate metabolism, a process controlled by multiple levels of phosphorylation (Roach, 2002). Although the overall carbohydrate machinery differs substantially between mammals and plants, both systems contain common phosphoproteins that share conserved functions (Preiss et al., 1983; Vikso-Nielsen et al., 2002; Coppin et al., 2005). These proteins would be likely substrate candidates for laforin and SEX4. To address this hypothesis, we tested the majority of the mammalian candidates, but none of them served as a substrate for laforin (Worby et al., 2006; our unpublished data).
It is interesting that laforin and SEX4 are functional equivalents that dephosphorylate a complex carbohydrate and that the mutation of either gene results in the accumulation of insoluble carbohydrates in vertebrates and plants, respectively. Our understanding of the metabolism of insoluble carbohydrates in vertebrate systems is still in its infancy. In contrast, the plant community has made substantial progress in understanding the metabolism of starch (Smith et al., 2005; Zeeman et al., 2007). In plants, it is clear that the phosphorylation of glucose residues within starch is required for its proper accumulation and degradation (Blennow et al., 2002; Smith et al., 2005; Zeeman et al., 2007). In A. thaliana, glucan water dikinase (Ritte et al., 2002) and phosphoglucan water dikinase (Baunsgaard et al., 2005; Kotting et al., 2005) phosphorylate glucose monomers within amylopectin at the C6 and C3 position (Ritte et al., 2006), respectively. As with SEX4, mutations in the genes encoding glucan water dikinase and phosphoglucan water dikinase also yield a starch excess phenotype (Yu et al., 2001; Baunsgaard et al., 2005; Kotting et al., 2005). Phosphorylation is necessary for both starch accumulation and degradation; however, the timing of these phosphorylation and dephosphorylation events is unknown (Smith et al., 2005; Zeeman et al., 2007). Intriguingly, although glycogen, the soluble storage carbohydrate in vertebrates, contains little to no phosphate, detrimental insoluble carbohydrates like LBs are highly phosphorylated, just like amylopectin in plant starch (Schnabel and Seitelberger, 1968; Sakai et al., 1970). Therefore, it appears logical that laforin and SEX4 evolved to perform the critical role of dephosphorylating insoluble carbohydrates to allow their proper degradation.
This basic function of insoluble carbohydrate metabolism provides an intriguing explanation for both the existence of a laforin-like activity in protists and plants and the role of laforin in preventing LD. In protists and plants, carbohydrate dephosphorylation would be necessary for the utilization of insoluble carbohydrates as an energy source. When this activity is absent, these organisms accumulate unusable starch as in the sex4 mutants. In vertebrates, laforin would dephosphorylate nascent insoluble carbohydrates to inhibit the formation of detrimental LBs. In the absence of laforin, these nascent molecules increase in size and number and eventually cause LD.
Our work clearly demonstrates that a laforin-like activity is necessary for the proper metabolism of insoluble carbohydrates. This activity is required throughout multiple kingdoms and regulates an overlooked aspect of carbohydrate metabolism. It is striking that protists and plants have provided new insights into a human neurodegenerative disease involving aberrant carbohydrate metabolism that was described almost 100 yr ago by Lafora and Gluck (Lafora, 1911; Lafora and Gluck, 1911).
| Materials and methods |
|---|
|
|
|---|
52-SEX4. pET21a VHR (Denu et al., 1995) and pET21a Hs-laforin (Wang et al., 2002) have been described previously. Hs-laforin, SEX4, and sex4-C198S were cloned in frame of a triple HA tag into pCHF1 (Neff et al., 1999), which is a modified version of pPZP221 (Hajdukiewicz et al., 1994). pCHF1 contains the 35S cauliflower mosaic virus promoter, the Rubisco terminator from pea, and confers gentamicin resistance for selection in plants. Because Kerk et al. (2006) and Niittyla et al. (2006) demonstrated that the cTP of SEX4 targets SEX4 to the chloroplast, we fused the cTP of SEX4 (nucleotides 1–213) in frame with Hs-laforin and the triple HA tag in pCHF to generate pCHF cTP–Hs-laforin. All point mutations were generated with the QuikChange Site-Directed Mutagenesis kit (Stratagene) according to the manufacturer's instructions. All constructs were verified by DNA sequencing. Recombinant proteins were expressed with a carboxy-terminal six-histidine tag in Escherichia coli BL21 (DE3) CodonPlus cells (Stratagene). Fusion proteins were expressed and purified from soluble bacterial extracts using Ni2+-agarose affinity chromatography as described previously (Gentry et al., 2005).
Phosphatase assays
Hydrolysis of p-NPP was performed in 50-µl reactions containing 1x phosphate buffer (0.1 M sodium acetate, 0.05 M bis-Tris, 0.05 M Tris-HCl, and 2 mM DTT at the appropriate pH), 50 mM pNPP, and 100–500 ng of enzyme at 37°C for 1–5 min. The reaction was terminated by the addition of 200 µl of 0.25 M NaOH, and absorbance was measured at 410 nm. We tested the specific activity of each enzyme at pH 5.0, 5.5, 6.0, 6.5, 7.0, 7.5, and 8.0. The optimal pH for each enzyme was as follows: Hs-laforin, pH 5.0; Cm-laforin, pH 5.5; SEX4, pH 6.0; and VHR, pH 6.0. Malachite green assays were performed as described previously (Harder et al., 1994) with the following modifications: 1x phosphate buffer, 100–500 ng of enzyme, and
45 µg of amylopectin in a final volume of 20 µl. The reaction was stopped by the addition of 20 µl of 0.1 M N-ethylmaleimide and 80 µl of malachite green reagent. Absorbance was measured at 620 nm. We tested the specific activity of each enzyme at the same pH units as above. The optimal pH for each enzyme was as follows: Hs-laforin, pH 7.0; Cm-laforin, pH 6.0; and SEX4, pH 8.0.
Phylogenetic analyses and sequence alignment
The sequences of laforin and SEX4 orthologues were obtained by performing tBLASTn searches using the GenBank dbEST database or BLASTp and PSI-BLAST (Altschul et al., 1997) searches using GenBank eukaryote genome and nr databases, the C. merolae genome project, Department of Energy Joint Genome Institute Resource, The Institute for Genomic Research, ToxoDB, GeneDB, Genoscope, and Tetrahymena Genome Database. Accession numbers are listed in Tables S2 and S5 (available at http://www.jcb.org/cgi/content/full/jcb.200704094/DC1). The web address for each database is listed in Table S1. A list of each genome that we investigated and a reason why an organism's genome lacks laforin is listed in Table S4. Amino acid sequences of laforin orthologues were aligned by ClustalW (Thompson et al., 1994) and refined manually using MacVector. Small subunit ribosomal RNA sequences were obtained by performing BLASTn using GenBank from all organisms and nr databases, and accession numbers are listed in Table S3. The phylogenetic tree was generated from a ClustalW (Thompson et al., 1994) multiple sequence alignment using PROTDIST and FITCH from the PHYLIP 3.65 software package and was displayed using HYPERTREE 1.0.0 (Pfizer; Bingham and Sudarsanam, 2000).
Plant material
Homozygous sex4-3 plants (T-DNA insertion line SALK_102567; Alonso et al., 2003) were isolated by PCR. Stable transgenic plant lines were generated by Agrobacterium-mediated floral dipping (Clough and Bent, 1998), and seeds were sterilized, plated on standard growth medium (Valvekens et al., 1988), and selected for using 100 µg/ml gentamycin per standard protocols (Valvekens et al., 1988; Clough and Bent, 1998). Plants were grown in Promix-HP soil at 22°C with supplemental lighting conditions of 16-h days. To stain starch in leaves, leaves were decolorized in 80% (vol/vol) ethanol, stained with an iodine solution, and destained in water. Starch content was quantified as previously described (Kotting et al., 2005). mRNA was obtained using an RNeasy Plant Mini kit (QIAGEN), and first-strand synthesis was performed using SuperScript III First-Strand Synthesis SuperMix (Invitrogen) according to the manufacture's recommendations. Four primer sets were used to test for the presence of transcripts in wild-type (Columbia) and sex4-3 plants. Three primer sets to the SEX4 transcript and a positive control to UBC5, the UBC5 primer set, was included in each PCR tube. Plant whole leaf lysate was obtained as described previously (Nimchuk et al., 2000).
Antibodies and Western analysis
The
–Hs-laforin and
–Cm-laforin antibodies were generated by immunizing rabbits with recombinant Hs-laforin or
–Cm-laforin, and antibodies were affinity purified from the serum with a HiTrap NHS-activated HP affinity column (GE Healthcare) of Hs-laforin or Cm-laforin protein, respectively. The
–Cm-laforin antibody was generated in a similar manner. Recombinant Hs-laforin and Cm-laforin were detected with their respective primary antibodies followed by goat
–rabbit HRP (GE Healthcare). Recombinant VHR and SEX4 were detected with
-HIS-HRP (Santa Cruz Biotechnology, Inc.). Protein expression of A. thaliana transgenes was monitored by Western analysis using rat anti-HA (clone 3F10; Roche) and goat
–rat HRP (Chemicon).
C. merolae cell culture, immunofluorescence, and immunogold electron microscopy
C. merolae 10D-14 (Toda et al., 1998) was provided by T. Kuroiwa and grown asynchronously at pH 2.5 in 2x Allens's medium at 42°C under continuous illumination as described previously (Minoda et al., 2004). For immunofluorescence, cells were fixed, washed, and blocked as previously described (Nishida et al., 2004). Cells were then probed with 1:100 preimmune serum or 1:1,000
–Cm-laforin antibody followed by 1:1,000 AlexaFluor488 goat
–rabbit antibody (Invitrogen). Chloroplasts were visualized by their autofluorescence. Immunofluorescence was performed using a light microscope (DMR; Leica) with a PL APO 63x 1.32 NA oil objective (Leica) at room temperature, and images were captured with a CCD camera (C4742-95; Hamamatsu) using OpenLab 4.0.1 software (Improvision). For immunogold EM, cells were fixed, washed, sectioned, and blocked as previously described (Nishida et al., 2003). Sections were immunostained with 1:50 preimmune serum or 1:250
–Cm-laforin antibody and with 10 nm of gold particle–conjugated goat
–rabbit antibody. Grids were viewed using a transmission electron microscope (1200EX II; JEOL), and images were collected using a digital camera (ORIUS SC600; Gatan) and Digital Micrograph software (Gatan). Photoshop (Adobe) and Illustrator (Adobe) were used to generate figures of all images.
Online supplemental material
Fig. S1 shows purified recombinant Cm-laforin and SEX4. Fig. S2 shows the phosphatase activity of Cm-laforin mutants using p-NPP and amylopectin as substrates. Fig. S3 shows immuno-EM of a C. merolae cell probed with the secondary antibody alone. Fig. S4 shows the phosphatase activity of SEX4 mutants using p-NPP and amylopectin as substrates. Fig. S5 shows the quantitation of starch in wild-type, sex4-3, and transgenic plants. Table S1 provides data about non-NCBI databases, Table S2 provides accession numbers for laforin orthologues, and Table S3 provides small subunit ribosomal RNA accession numbers. Table S4 provides data about the genomes investigated for the presence of laforin, and Table S5 provides accession numbers for AMPKß-GBD proteins and SEX4 orthologues. Online supplemental material is available at http://www.jcb.org/cgi/content/full/jcb.200704094/DC1.
| Acknowledgments |
|---|
This work was supported by National Institutes of Health (NIH) grants DK18024-31 and DK18849-31 to J.E. Dixon, grants T32 CA09523 and T32 HD 007203-23 to M.S. Gentry, grant T32 DK 07494 to S. Mattoo, and grant T32 GM07752 to R.H. Dowen as well as by the Walther Cancer Institute.
Submitted: 17 April 2007
Accepted: 29 June 2007
| References |
|---|
|
|
|---|
Alonso, A., J. Sasin, N. Bottini, I. Friedberg, I. Friedberg, A. Osterman, A. Godzik, T. Hunter, J. Dixon, and T. Mustelin. 2004. Protein tyrosine phosphatases in the human genome. Cell. 117:699–711.[CrossRef][Medline]
Alonso, J.M., A.N. Stepanova, T.J. Leisse, C.J. Kim, H. Chen, P. Shinn, D.K. Stevenson, J. Zimmerman, P. Barajas, R. Cheuk, et al. 2003. Genome-wide insertional mutagenesis of Arabidopsis thaliana. Science. 301:653–657.
Altschul, S.F., T.L. Madden, A.A. Schaffer, J. Zhang, Z. Zhang, W. Miller, and D.J. Lipman. 1997. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25:3389–3402.
Bateman, A., L. Coin, R. Durbin, R.D. Finn, V. Hollich, S. Griffiths-Jones, A. Khanna, M. Marshall, S. Moxon, E.L.L. Sonnhammer, et al. 2004. The Pfam protein families database. Nucleic Acids Res. 32:D138–D141.
Baunsgaard, L., H. Lutken, R. Mikkelsen, M.A. Glaring, T.T. Pham, and A. Blennow. 2005. A novel isoform of glucan, water dikinase phosphorylates pre-phosphorylated alpha-glucans and is involved in starch degradation in Arabidopsis. Plant J. 41:595–605.[CrossRef][Medline]
Bhattacharya, D., and L. Medlin. 1998. Algal phylogeny and the origin of land plants. Plant Physiol. 116:9–15.
Bingham, J., and S. Sudarsanam. 2000. Visualizing large hierarchical clusters in hyperbolic space. Bioinformatics. 16:660–661.
Blennow, A., T.H. Nielsen, L. Baunsgaard, R. Mikkelsen, and S.B. Engelsen. 2002. Starch phosphorylation: a new front line in starch research. Trends Plant Sci. 7:445–450.[CrossRef][Medline]
Boraston, A.B., D.N. Bolam, H.J. Gilbert, and G.J. Daview. 2004. Carbohydrate-binding modules: fine-tuning polysaccharide recognition. Biochem. J. 382:769–781.[CrossRef][Medline]
Carpenter, S., and G. Karpati. 1981. Sweat gland duct cells in Lafora disease: diagnosis by skin biopsy. Neurology. 31:1564–1568.
Cavalier-Smith, T. 1982. The origin of plastids. Biol. J. Linn. Soc. 17:289–306.
Cavalier-Smith, T. 1999. Principles of protein and lipid targeting in secondary symbiogenesis: Euglenoid, dinoflagellatae, and sporozoan plastid origins and the eukaryote family tree. J. Euk. Microbiol. 46:347–366.[CrossRef][Medline]
Cavalier-Smith, T. 2004. Only six kingdoms of life. Proc. R. Soc. Lond. B. 271:1251–1262.[Medline]
Chan, E.M., E.J. Young, L. Ianzano, I. Munteanu, X. Zhao, C.C. Christopoulos, G. Avanzini, M. Elia, C.A. Ackerley, N.J. Jovic, et al. 2003. Mutations in NHLRC1 cause progressive myoclonus epilepsy. Nat. Genet. 35:125–127.[CrossRef][Medline]
Chan, E.M., C.A. Ackerley, H. Lohi, L. Ianzano, M.A. Cortez, P. Shannon, S.W. Scherer, and B.A. Minassian. 2004. Laforin preferentially binds the neurotoxic starch-like polyglucosans, which form in its absence in progressive myoclonus epilepsy. Hum. Mol. Genet. 13:1117–1129.
Chung, J.K., F. Sekiya, H.S. Kang, C. Lee, J.S. Han, S.R. Kin, Y.S. Bae, A.J. Morris, and S.G. Rhee. 1997. Synaptojanin inhibition of phospholipase D activity by hydrolysis of phospatidylinositol 4,5-bisphosphate. J. Biol. Chem. 272:15980–15985.
Clough, S.J., and A.F. Bent. 1998. Floral dip: a simplified method for Agrobacterium-mediated transformation of Arabidopsis thaliana. Plant J. 16:735–743.[CrossRef][Medline]
Collins, G.H., R.R. Cowden, and A.H. Nevis. 1968. Myoclonus epilepsy with Lafora bodies. An ultrastructural and cytochemical study. Arch. Pathol. 86:239–254.[Medline]
Coppin, A., F. Dzierszinski, S. Legrand, M. Mortuaire, D. Ferguson, and S. Tomavo. 2003. Developmentally regulated biosynthesis of carbohydrate and storage polysaccharide during differentiation and tissue cyst formation in Toxoplasma gondii. Biochimie. 85:353–361.[Medline]
Coppin, A., J. Varré, L. Lienard, D. Dauvillée, Y. Guérardel, M. Soyer-Gobillard, A. Buléon, S. Ball, and Stanislas Tomavo. 2005. Evolution of plant-like crystalline storage polysaccharide in the protozoan parasite Toxoplasma gondii argues for a red alga ancestry. J. Mol. Evol. 60:257–267.[CrossRef][Medline]
Coutinho, P.M., and B. Henrissat. 1999. Carbohydrate-active enzymes: an integrated database approach. In Recent Advances in Carbohydrate Bioengineering. H.J. Gilbert, G.J. Davies, B. Henrissat, and B. Svensson, editors. Royal Society of Chemistry, Cambridge. 3–12.
Denu, J.M., G. Zhou, L. Wu, R. Zhao, J. Yuvaniyama, M.A. Saper, and J.E. Dixon. 1995. The purification and characterization of a human dual- specific protein tyrosine phosphatase. J. Biol. Chem. 270:3796–3803.
Denu, J.M., J.A. Stuckey, M.A. Saper, and J.E. Dixon. 1996. Form and function in protein dephosphorylation. Cell. 87:361–364.[CrossRef][Medline]
Dubey, J.P., D.S. Lindsay, and C.A. Speer. 1998. Structures of Toxoplasma gondii tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts. Clin. Microbiol. Rev. 11:267–299.
Embley, T.M., and W. Martin. 2006. Eukaryotic evolution, changes and challenges. Nature. 440:623–630.[CrossRef][Medline]
Fordham-Skelton, A.P., P. Chilley, V. Lumbreras, S. Reignoux, T.R. Fenton, C.C. Dahm, M. Pages, and J.A. Gatehouse. 2002. A novel higher plant protein tyrosine phosphatase interacts with SNF1-related protein kinases via a KIS (kinase interaction sequence) domain. Plant J. 29:705–715.[CrossRef][Medline]
Ganesh, S., K.L. Agarwala, K. Ueda, T. Akagi, K. Shoda, T. Usui, T. Hashikawa, H. Osada, A.V. Delgado-Escueta, and K. Yamakawa. 2000. Laforin, defective in the progressive myoclonus epilepsy of Lafora type, is a dual-specificity phosphatase associated with polyribosomes. Hum. Mol. Genet. 9:2251–2261.
Ganesh, S., K.L. Agarwala, K. Amano, T. Suzuki, A.V. Delgado-Escueta, and K. Yamakawa. 2001. Regional and developmental expression of Epm2a gene and its evolutionary conservation. Biochem. Biophys. Res. Commun. 283:1046–1053.[CrossRef][Medline]
Ganesh, S., A.V. Delgado-Escueta, T. Sakamoto, M.R. Avila, J. Machado-Salas, Y. Hoshii, T. Akagi, H. Gomi, T. Suzuki, K. Amano, et al. 2002. Targeted disruption of the Epm2a gene causes formation of Lafora inclusion bodies, neurodegeneration, ataxia, myoclonus epilepsy and impaired behavioral response in mice. Hum. Mol. Genet. 11:1251–1262.
Ganesh, S., N. Tsurutani, T. Suzuki, Y. Hoshii, T. Ishihara, A.V. Delgado-Escueta, and K. Yamakawa. 2004. The carbohydrate-binding domain of Lafora disease protein targets Lafora polyglucosan bodies. Biochem. Biophys. Res. Commun. 313:1101–1109.[CrossRef][Medline]
Gentry, M.S., C.A. Worby, and J.E. Dixon. 2005. Insights into Lafora disease: Malin is an E3 ubiquitin ligase that ubiquitinates and promotes the degradation of laforin. Proc. Natl. Acad. Sci. USA. 102:8501–8506.
Gillott, M.A., and S.P. Gibbs. 1980. The cryptomonad nucleomorth: its ultrastructure and evolutionary significance. J. Phycol. 16:558–568.[CrossRef]
Guérardel, Y., D. Leleu, A. Coppin, L. Liénard, C. Slomianny, G. Strecker, S. Ball, and S. Tomavo. 2005. Amylopectin biogenesis and characterization in the protozoan parasite Toxoplasma gondii, the intracellular development of which is restricted in the HepG2 cell line. Microbes Infect. 7:41–48.[CrossRef][Medline]
Guo, S., L.E. Stolz, S.M. Lemrow, and J.D. York. 1999. SAC1-like domains of yeast SAC1, INP52, and INP53 and of human synaptojanin encode polyphosphoinositide phosphatases. J. Biol. Chem. 274:12990–12995.
Hajdukiewicz, P., Z. Svab, and P. Maliga. 1994. The small, versatile pPZP family of Agrobacterium binary vectors for plant transformation. Plant Mol. Biol. 25:989–994.[CrossRef][Medline]
Harder, K.W., P. Owen, L.K. Wong, R. Aebersold, I. Clark-Lewis, and F.R. Jirik. 1994. Characterization and kinetic analysis of the intracellular domain of human protein tyrosine phosphatase beta (HPTP beta) using synthetic phosphopeptides. Biochem. J. 298:395–401.[Medline]
Harriman, D.G., J.H. Millar, and A.C. Stevenson. 1955. Progressive familial myoclonic epilepsy in three families: its clinical features and pathological basis. Brain. 78:325–349.
Hughes, W.E., F.T. Cooke, and P.J. Parker. 2000. Sac phosphatase domain proteins. Biochem. J. 350:337–352.[CrossRef][Medline]
Ianzano, L., J. Zhang, E.M. Chan, X. Zhao, H. Lohi, S.W. Scherer, and B.A. Minassian. 2005. Lafora progressive Myoclonus Epilepsy mutation database-EPM2A and NHLRC1 (EMP2B) genes. Hum. Mutat. 26:397.[Medline]
Kerk, D., T.R. Conley, F.A. Rodriguez, H.T. Tran, M. Nimick, D.G. Muench, and G.B. Moorhead. 2006. A chloroplast-localized dual-specificity protein phosphatase in Arabidopsis contains a phylogenetically dispersed and ancient carbohydrate-binding domain, which binds the polysaccharide starch. Plant J. 46:400–413.[CrossRef][Medline]
Kissinger, J.C., B. Gajria, L. Li, I.T. Paulsen, and D.S. Roos. 2003. ToxoDB: accessing the Toxoplasma gondii genome. Nucleic Acids Res. 31:234–236.
Kotting, O., K. Pusch, A. Tiessen, P. Geigenberger, M. Steup, and G. Ritte. 2005. Identification of a novel enzyme required for starch metabolism in Arabidopsis leaves. The phosphoglucan, water dikinase. Plant Physiol. 137:242–252.
Lafora, G.R. 1911. Uber des Vorkommen amyloider KJrperchen im innern der Ganglienzellen. Virchows Arch. f. Path. Anat. 205:295.[CrossRef]
Lafora, G.R., and B. Gluck. 1911. Beitrag zur histopathologie der myoklonischen epilepsie. Z Ges Neurol Psychiatr. 6:1–14.
Maehama, T., and J.E. Dixon. 1998. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem. 273:13375–13378.
Marchler-Bauer, A., J.B. Anderson, P.F. Cherukuri, C. DeWeese-Scott, L.Y. Geer, M. Gwadz, S. He, D.I. Hurwitz, J.D. Jackson, Z. Ke, et al. 2005. CDD: a Conserved Domain Database for protein classification. Nucleic Acids Res. 33:D192–D196.
Minassian, B.A., J.R. Lee, J.A. Herbrick, J. Huizenga, S. Soder, A.J. Mungall, I. Dunham, R. Gardner, C.Y. Fong, S. Carpenter, et al. 1998. Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy. Nat. Genet. 20:171–174.[CrossRef][Medline]
Minoda, A.,